Jupiter Neurosciences Introduces Nugevia™ MND for Cognitive Health

JUNS
September 18, 2025
Jupiter Neurosciences, Inc. introduced Nugevia™ MND on August 11, 2025, a scientifically formulated supplement designed to protect and enhance cognitive function. This product leverages clinically validated neuroscience. Nugevia™ MND combines Jupiter's proprietary resveratrol-based platform, JOTROL™, with NovaSOL® Curcumin. This blend aims to support neuroprotective health and improve cognitive performance. This new offering expands the Nugevia™ consumer longevity product line, demonstrating Jupiter's commitment to addressing various aspects of healthy aging. It further solidifies the company's dual-path strategy in the wellness market. The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.